We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MGRX market cap is 6.24M. The company's latest EPS is USD -3.8383 and P/E is -0.66.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Revenue | 141k | 245k | 244k | 214k | 163k |
Operating Income | -2.29M | -1.8M | -2.57M | -2.37M | -2.17M |
Net Income | -2.28M | -1.8M | -2.57M | -2.37M | -2.39M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 9k | 731k |
Operating Income | -18k | -1.99M | -9.22M |
Net Income | -18k | -2M | -9.21M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Assets | 3.3M | 1.6M | 1.05M | 301k | 15.24M |
Total Liabilities | 294k | 241k | 276k | 1.26M | 1.41M |
Total Equity | 3M | 1.36M | 775k | -958k | 13.83M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 23k | 1M | 1.05M |
Total Liabilities | 40k | 389k | 276k |
Total Equity | -17k | 614k | 775k |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Operating | -3.59M | -5.3M | -7M | -991k | -2.57M |
Investing | -4k | -4k | -4k | N/A | 65k |
Financing | 5.86M | 5.86M | 7.06M | 267k | 2.26M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -18k | -1.35M | -7M |
Investing | N/A | -43k | -4k |
Financing | 41k | 2.05M | 7.06M |
Market Cap | 6.24M |
Price to Earnings Ratio | -0.66 |
Price to Sales Ratio | 8.31 |
Price to Cash Ratio | 8.22 |
Price to Book Ratio | 7.83 |
Dividend Yield | - |
Shares Outstanding | 2.4M |
Average Volume (1 week) | 100.69k |
Average Volume (1 Month) | 82.04k |
52 Week Change | -68.50% |
52 Week High | 16.80 |
52 Week Low | 2.10 |
Spread (Intraday) | 0.07 (2.72%) |
Company Name | Mangoceuticals Inc |
Address |
15110 n. dallas parkway, suite 600 dallas, texas 75248 |
Website | https://www.mangorx.com |
Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions